Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Save money

GLP-1 drug prices

8 min read · Updated · FairPill editorial team

GLP-1 medicines such as Ozempic, Wegovy, Mounjaro and Zepbound are among the most talked-about and most expensive drugs in the United States. Demand has been enormous, coverage is inconsistent, and a market of compounded and counterfeit versions has grown up around them. This guide explains what these drugs are, why they cost so much, how coverage differs for diabetes and weight management, and what to watch out for.

Key takeaways

  • The main GLP-1 drugs are brand-name products with no US generic versions of semaglutide or tirzepatide yet.
  • For brand drugs like these, pharmacy acquisition cost is usually close to the list price.
  • Medicare's negotiated price for semaglutide (Ozempic, Rybelsus, Wegovy) is $274 for a 30-day supply from January 1, 2027, down from a list price of $959.
  • Coverage is often much better when these drugs are prescribed for type 2 diabetes than for weight management.
  • The FDA has warned about risks from compounded and counterfeit versions.
  • Never buy a GLP-1 drug without a prescription or from an unlicensed seller.

The main GLP-1 drugs

BrandActive ingredientFormMain approved use
OzempicSemaglutideWeekly injection (pen)Type 2 diabetes
WegovySemaglutideWeekly injection (pen)Chronic weight management; cardiovascular risk reduction in certain adults
RybelsusSemaglutideDaily tabletType 2 diabetes
MounjaroTirzepatideWeekly injectionType 2 diabetes
ZepboundTirzepatideWeekly injectionChronic weight management; obstructive sleep apnea in certain adults with obesity
TrulicityDulaglutideWeekly injection (pen)Type 2 diabetes

Tirzepatide acts on two hormone receptors (GIP and GLP-1), while the others act on GLP-1, but they are often discussed together. Approved uses have been expanding, so check the current label for each product. Our guide to understanding drug label changes explains how to follow updates.

Why they are so expensive

  • Patent protection. Semaglutide, tirzepatide and dulaglutide are still protected by patents and exclusivity in the US, so there is no generic competition. Read when will a generic be available for how this works. (An older GLP-1, liraglutide, has had generic versions become available.)
  • High list prices. List prices for these drugs are commonly in the high hundreds to over a thousand dollars per month.
  • Huge demand. With so many potential users, manufacturers have had little pressure to cut prices, and supply has at times struggled to keep up.
  • Rebates and coverage decisions. As with many brands, much of the discounting happens through confidential rebates to insurers and PBMs, which patients do not see at the counter. See why are drug prices so expensive.

List price vs acquisition cost

For cheap generics, what a pharmacy pays can be a tiny fraction of the cash price. Brand-name GLP-1 drugs are different: the pharmacy's acquisition cost, as measured by NADAC, is usually close to the manufacturer's list price. That means a pharmacy cannot sell these drugs for much less than list without losing money, and the room for savings by shopping between pharmacies is smaller. The larger savings usually come from insurance coverage, manufacturer programs or, for Medicare enrollees, negotiated prices.

You can see current acquisition costs on our Ozempic page and compare others using search.

Medicare and the negotiated semaglutide price

Ozempic, Rybelsus and Wegovy were selected together for Medicare price negotiation. The negotiated price of $274 for a 30-day supply takes effect on January 1, 2027, compared with a list price of $959. What an individual pays will still depend on their Part D plan's copay or coinsurance and the annual out-of-pocket cap. Trulicity was selected in January 2026 for negotiated prices starting in 2028. Details are on our Medicare drug prices page and in Medicare drug price negotiation explained.

Coverage: diabetes vs weight management

Coverage often depends on why the drug is prescribed:

  • Type 2 diabetes. Drugs such as Ozempic, Mounjaro, Rybelsus and Trulicity are commonly covered by Medicare Part D, Medicaid and private plans for diabetes, often with prior authorization.
  • Weight management. By law, Medicare Part D has generally excluded drugs used for weight loss. Coverage may be possible when a drug is prescribed for another approved use, such as cardiovascular risk reduction or sleep apnea. Rules in this area have been under active discussion and can change, so check your plan's current policy.
  • Private insurance and Medicaid. Coverage of weight management drugs varies widely by employer, plan and state. Many plans require prior authorization, documentation of weight or other conditions, or participation in a lifestyle program.

Both main manufacturers have also offered self-pay options for some products at prices below list, sometimes for specific forms such as single-dose vials. Terms change often, so check the manufacturer's official website and compare the price with the fair cash price.

Compounded and counterfeit versions: cautions

When semaglutide and tirzepatide were on the FDA shortage list, compounding pharmacies were permitted to make copies. After the FDA determined those shortages were resolved, the rules for compounding these drugs became much stricter. The FDA has issued warnings about:

  • Dosing errors with compounded products, including patients measuring the wrong amount from multi-dose vials.
  • Unapproved ingredients, such as salt forms of semaglutide that differ from the approved drug.
  • Counterfeit products, including fake pens found in the US supply chain.
  • Illegal online sellers offering these drugs without a prescription, sometimes labeled "for research use only".

Compounded drugs are not FDA-approved, which means the FDA has not reviewed their safety, effectiveness or quality. If you are considering a compounded product, discuss it with your prescriber and pharmacist first.

Steps to pay less safely

  1. Ask your prescriber which product and dose are appropriate for you, and get a valid prescription.
  2. Check your plan's coverage, including any prior authorization and the reason the drug is prescribed.
  3. If you have commercial insurance, check the manufacturer's savings program.
  4. If you are paying cash, compare the manufacturer's self-pay price, pharmacy cash prices and the fair cash price on FairPill.
  5. If you have Medicare, check how the negotiated price and the Part D cap affect your costs.
  6. Only use licensed US pharmacies that require a prescription. Check pens for signs of tampering and ask your pharmacist if anything looks wrong.
  7. Report suspected counterfeit products or side effects to FDA MedWatch at fda.gov/medwatch or 1-800-FDA-1088.
Free toolIs my drug price fair? Check any quote

Prices for these drugs are changing fast. Set up alerts to follow them, and if you have filled a GLP-1 prescription recently, please share what you paid - real counter prices are especially valuable for these medicines.

This guide is general information, not medical or financial advice. Talk to your pharmacist or prescriber about your own medicines.

Questions about this guide

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.